These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22085801)

  • 1. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.
    Elzi L; Steffen I; Furrer H; Fehr J; Cavassini M; Hirschel B; Hoffmann M; Bernasconi E; Bassetti S; Battegay M
    BMC Infect Dis; 2011 Nov; 11():319. PubMed ID: 22085801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
    Chkhartishvili N; Kempker RR; Dvali N; Abashidze L; Sharavdze L; Gabunia P; Blumberg HM; Del Rio C; Tsertsvadze T
    BMC Infect Dis; 2013 Nov; 13():513. PubMed ID: 24176032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
    Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
    BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good Agreement between an Interferon Gamma Release Assay and Tuberculin Skin Tests in Testing for Latent Tuberculosis Infection among HIV-Infected Patients in Indonesia.
    Reviono R; Saptawati L; Redhono D; Suryawati B
    J Korean Med Sci; 2019 Oct; 34(40):e259. PubMed ID: 31625291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
    Binay UD; Fincancı M; Fersan E; Karakeçili F
    Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil.
    Kussen GM; Dalla-Costa LM; Rossoni A; Raboni SM
    Braz J Infect Dis; 2016; 20(1):69-75. PubMed ID: 26706018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.
    Sultan B; Benn P; Mahungu T; Young M; Mercey D; Morris-Jones S; Miller RF
    Int J STD AIDS; 2013 Oct; 24(10):775-9. PubMed ID: 23970606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
    Krutikov M; Faust L; Nikolayevskyy V; Hamada Y; Gupta RK; Cirillo D; Mateelli A; Korobitsyn A; Denkinger CM; Rangaka MX
    Lancet Infect Dis; 2022 Feb; 22(2):250-264. PubMed ID: 34606768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
    Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
    Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.
    LaCourse SM; Cranmer LM; Matemo D; Kinuthia J; Richardson BA; Horne DJ; John-Stewart G
    J Acquir Immune Defic Syndr; 2017 May; 75(1):128-136. PubMed ID: 28141782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculin skin test and interferon-γ release assays: Can they agree?
    Santos JA; Duarte R; Nunes C
    Clin Respir J; 2023 Feb; 17(2):109-114. PubMed ID: 36526296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
    Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
    Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.